| Classification of progression patterns in glioblastoma: analysis of predictive factors and clinical implications H Jiang, K Yu, M Li, Y Cui, X Ren, C Yang, X Zhao, S Lin Frontiers in oncology 10, 590648, 2020 | 40 | 2020 |
| Combination of immunotherapy and radiotherapy for recurrent malignant gliomas: results from a prospective study H Jiang, K Yu, Y Cui, X Ren, M Li, C Yang, X Zhao, Q Zhu, S Lin Frontiers in Immunology 12, 632547, 2021 | 19 | 2021 |
| Orelabrutinib combined with lenalidomide and immunochemotherapy for relapsed/refractory primary central nervous system lymphoma: a retrospective analysis of case series C Yang, Y Cui, X Ren, M Li, K Yu, S Shen, H Jiang, M Li, X Zhang, X Zhao, ... Frontiers in Oncology 12, 901797, 2022 | 18 | 2022 |
| Distinguishing pseudoprogression from true early progression in isocitrate dehydrogenase wild-type glioblastoma by interrogating clinical, radiological, and molecular features M Li, X Ren, G Dong, J Wang, H Jiang, C Yang, X Zhao, Q Zhu, Y Cui, ... Frontiers in oncology 11, 627325, 2021 | 16 | 2021 |
| Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma M Li, G Dong, W Zhang, X Ren, H Jiang, C Yang, X Zhao, Q Zhu, M Li, ... Cancer Science 112 (9), 3699-3710, 2021 | 14 | 2021 |
| Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma M Li, X Ren, X Chen, J Wang, S Shen, H Jiang, C Yang, X Zhao, Q Zhu, ... European Radiology 32 (6), 3869-3879, 2022 | 10 | 2022 |
| Differential predictors and clinical implications associated with long-term survivors in IDH wildtype and mutant glioblastoma H Jiang, K Yu, Y Cui, X Ren, M Li, G Zhang, C Yang, X Zhao, Q Zhu, S Lin Frontiers in Oncology 11, 632663, 2021 | 10 | 2021 |
| Extraventricular neurocytoma at the sellar region: Report of 8 cases and literature review X Zhao, M Li, G Zhang, X Ren, S Yu, H Jiang, Y Cui, S Lin Journal of Clinical Neuroscience 99, 379-386, 2022 | 6 | 2022 |
| Characterization and clinical implications of different malignant transformation patterns in diffuse low‐grade gliomas H Jiang, Q Zhu, X Wang, M Li, S Shen, C Yang, X Zhao, M Li, G Ma, ... Cancer Science 114 (9), 3708-3718, 2023 | 4 | 2023 |
| The sinuous, wave-like intratumoral-wall sign is a sensitive and specific radiological biomarker for oligodendrogliomas M Li, J Wang, X Chen, G Dong, W Zhang, S Shen, H Jiang, C Yang, ... European Radiology 33 (6), 4440-4452, 2023 | 4 | 2023 |
| Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas M Li, F Gao, X Ren, G Dong, H Chen, AY Lin, DD Wang, M Liu, PP Lin, ... Cancer Science 113 (10), 3535-3546, 2022 | 3 | 2022 |
| Nomograms for predicting cancer-specific survival in patients with primary central nervous system lymphoma: a population-based analysis C Yang, X Ren, Y Cui, H Jiang, K Yu, M Li, X Zhao, Q Zhu, S Lin Annals of Translational Medicine 9 (13), 2021 | 3 | 2021 |
| Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and … M Li, X Ren, G Dong, J Wang, H Jiang, C Yang, X Zhao, Q Zhu, Y Cui, ... Frontiers in Oncology 11, 700599, 2021 | 1 | 2021 |
| Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis X Zhao, R Li, Y Guo, H Wan, D Zhou Neurosurgical Review 47 (1), 1-11, 2024 | | 2024 |
| A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma Q Zhu, S Shen, C Yang, M Li, X Zhang, H Li, X Zhao, M Li, Y Cui, X Ren, ... Frontiers in Neurology 13, 1074593, 2022 | | 2022 |
| Prognostic Estimation Model for Oligodendroglioma: An mRNA-Sequence Data-Based Analysis Q Zhu, S Shen, C Yang, M Li, X Zhang, H Li, X Zhao, M Li, C Yong, X Ren, ... | | 2022 |
| T2/FLAIR Abnormity Could Be the Early Sign of Glioblastoma Dissemination M Li, W Huang, H Chen, H Jiang, C Yang, S Shen, X Zhang, X Zhao, ... | | 2021 |
